Obsessive–compulsive symptoms in schizophrenia: Prevalence, clinical features and treatment. A literature review

References

• Abbruzzese M, Bellodi L, Scarone S. 1995. Frontal lobe dysfunction in schizophrenia and obsessive–compulsive disorder: a neuropsychological study. Brain Cogn 27:202–212.
   PubMed Web of Science ®Google Scholar
• Abbruzzese M, Ferri S, Scarone S. 1997. The selective breakdown of frontal functions in patients with obsessive–compulsive disorder and in patients with schizophrenia: A double dissociation experimental finding. Neuropsychologia 35:907–912.
   PubMed Web of Science ®Google Scholar
• Adler CM, Strakowski SM. 2003. Boundaries of schizophrenia. Psychiatr Clin North Am 26(1):1–23.
   Google Scholar
• Alevizos B, Lykouras L, Zervas IM, Christodoulou GN. 2002. Risperidone-induced obsessive–compulsive symptoms. A series of six cases. J Clin Psychopharmacol 22:461–467.
   PubMed Web of Science ®Google Scholar
• Alevizos B, Papageorgiou C, Christodoulou GN. 2004. Obsessive–compulsive symptoms with olanzapine. Int J Neuropsychopharmacol 7(3):375–377.
   Google Scholar
• Allen L, Tejera C. 1994. Treatment of clozapine induced obsessive-compulsive symptoms with sertraline. Am J Psychiatry 151:1096–1097.
   PubMed Web of Science ®Google Scholar
• Alzaid K, Jones BD. 1997. A case of risperidone induced obsessive–compulsive symptoms. J Clin Psychopharmacol 17:58–59.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. 4th. American Psychiatric Association Washington DC.
   Google Scholar
• Andrews G, Stewart G, Allen R, Henderson AS. 1990. The genetics of six neurotic disorders: a twin study. J Affect Disord 19(1):23–29.
   Google Scholar
• Baker RW. 1992. Fluoxetine and schizophrenia in a patient with obsessional thinking. J Neuropsychiatry Clin Neurosci 4: 232–233.
   Google Scholar
• Baker RW, Chendappa KNR, Baird JW, Steingard S, Christ MAG, Shooler NR. 1992. Emergence of obsessive–compulsive symptoms during treatment with clozapine. J Clin Psychiatry 53:439–442.
   PubMed Web of Science ®Google Scholar
• Baker RW, Ames D, Umbricht DS, Chengappa KN, Schooler NR. 1996. Obsessive-compulsive symptoms in schizophrenia: A comparison of olanzapine and placebo. Psychopharmacol Bull 32:89–93.
   PubMedGoogle Scholar
• Bark N, Lindenmayer JP. 1992. Ineffectiveness of clomipramine for obsessive–compulsive symptoms in a patient with schizophrenia (letter). Am J Psychiatry 141:136–137.
   Google Scholar
• Berman I, Kalinowski A, Berman S, Lengua J, Green A. 1995a. Obsessions and compulsions in chronic schizophrenia. Compr Psychiatry 36:6–10.
   PubMed Web of Science ®Google Scholar
• Berman I, Sapers BC, Chang HH, Losenczy MF, Schmildler J, Green AI. 1995b. Treatment of obsessive–compulsive symptoms in schizophrenic patients with clomipramine. J Clin Psychopharmacol 15:206–210.
   PubMedGoogle Scholar
• Berman I, Merson A, Viegner B, Losonczy MF, Pappas D, Green AI. 1998. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia : A neuropsychological study. J Nerv Ment Dis 186:150–156.
   PubMed Web of Science ®Google Scholar
• Berman I, Chang HH, Klegon DA. 1999. Obsessive–compulsive symptoms in schizophrenia: Neuropsychological perspectives. Psychiatry Ann 29:525–528.
   Google Scholar
• Bland RC, Newman SC, Orn H. 1987. Schizophrenia: Lifetime co-morbidity in a community sample. Acta Psychiatr Scand 75:383–391.
   PubMed Web of Science ®Google Scholar
• Borkowska A, Pilaczynska E, Rybakowski JK. 2003. The frontal lobe neuropsychological tests in patients with schizophrenia and/or obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 15(3):359–362.
   Google Scholar
• Bottas A, Cooke RG, Richter MA. 2005. Comorbidity and pathopysiology of obsessive–compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci 30(3):187–193.
   Google Scholar
• Boyette L, Swets M, Meijer C, Wouters L, GROUP authors. 2010. Factor structure of the Yale-Brown Obsessive–compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive–compulsive symptoms. Psychiatry Res Aug 26: Epub ahead of print.
   Google Scholar
• Cassady SL, Thaker GK. 1992. Addition of fluoxetine to clozapine. Am J Psychiatry 149:1274.
   PubMed Web of Science ®Google Scholar
• Cavallaro R, Cavendini P, Mistretta P, Bassi T, Angelone SM, Ubbiali A, Bellodi L. 2003. Basal-corticofrontal circuits in schizophrenia and obsessive–compulsive disorder: A controlled, double dissociation study. Biol Psychiatry 54:437–443.
   PubMed Web of Science ®Google Scholar
• Chaves MPR, Crippa JA, Morias SL, Zvardi AW. 2005. Electroconvulsive therapy for co-existent schizophrenia and obsessive–compulsive disorder. J Clin Psychiatry 66(4):512–513.
   Google Scholar
• Chiao-Li K, Cheng-Fang Y, Cheng-Chung C, Shang-Ju Y, Weilun C, Ming-Jen Y. 2004. Obsessive-compulsive symptoms associated with clozapine and risperidone treatment. Three case reports and review of the literature. Kaohsiung J Med Sci 20(6):295–301.
   Google Scholar
• Craig T, Hwang MY, Bromet EJ. 2002. Obsessive–compulsive and panic symptoms in patients with first-admission psychosis. Am J Psychiatry 159:592–598.
   PubMed Web of Science ®Google Scholar
• Cummings JL. 1993. Frontal–subcortical circuits and human behaviour. Arch Neurol 50:873–880.
   PubMed Web of Science ®Google Scholar
• Cunill R, Castells X, Simeon D. 2009. Relationships between obsessive-compulsive symptomatology and severity of psychosis in schizophrenia: A systematic review and meta-analysis. J Clin Psychiatry 70(1):70–82.
   Google Scholar
• De Haan L, Linszen D, Gorsira R.1999. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry 60(6):364–365.
   Google Scholar
• De Haan L, Beuk N, Hoogenboom B, Dingermans P. 2002. Obsessive–compulsive symptoms during treatment with olanzepine and risperidone: a prospective study of 113 patients with recent onset schizophrenia or related disorders. J Clin Psychiatry 63:104–107.
   PubMed Web of Science ®Google Scholar
• De Haan L, Oekeneva A, Van Amelsvoort T, Linzsen D. 2004. Obsessive–compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. Eur Psychiatry 19:524.
   Google Scholar
• De Haan L, Hoogenboom B, Beuk N, Dingemans P, Van Amelsvoort T, Linszen D. 2005. Obsessive–compulsive symptoms distinct from positive and negative symptoms in patients with recent-onset schizophrenia. Can J Psychiatry 50:519–524.
   Google Scholar
• De Haan L, Hoogeboom B, Beuk N, Wouters L, Dingemans PM, Linszen DH. 2006. Reliability and validity of the Yale-Brown Obsessive–compulsive Scale in schizophrenia patients. Psychopharmacol Bull 39:25–30.
   PubMedGoogle Scholar
• Dodt JE, Byerly MJ, Cuadros C, Christensen RC. 1997. Treatment of risperidone-induced obsessive–compulsive symptoms with sertraline. Am J Psychiatry 154(4):582.
   Google Scholar
• Eales MJ, Layeni AO. 1994. Exacerbation of obsessive–compulsive c symptoms associated with clozapine. Br J Psychiatry 164:687–688.
   Google Scholar
• Eisen JL, Rasmussen SA. 1993. Obsessive-compulsive disorder with psychotic features. J Clin Psychiatry 54:373–379.
   PubMed Web of Science ®Google Scholar
• Englisch S, Esslinger C, Inta D, Weinbrenner A, Peus V, Gutschalk A, . 2009. Clozapine-induced obsessive–compulsive symptoms improve in combination with aripiprazole. Clin Neuropharmacol 32(4):227–229.
   Google Scholar
• Fabisch K, Fabisch H, Langs G, Weiselmann G, Zapotoczky HG. 1997. Obsessive-compulsive symptoms in schizophrenia. Schizophr Res 24:17.
   Google Scholar
• Fenton W, McGlashan T. 1986. The prognostic significance of obsessive–compulsive symptoms in schizophrenia. Am J Psychiatry 143:437–441.
   PubMed Web of Science ®Google Scholar
• First M, Spitzer R, Gibson M, Williams J. 1994. Structured Clinical Interview for DSM-IV Axis I Disorders, Administration Booklet. Washington, DC: American Psychiatric Press Inc.
   Google Scholar
• Ghaemi SN, Zarate CA, Popli SP, Pillay SS, Cole JO. 1995. Is there a relationship between clozapine and obsessive–compulsive disorder? A retrospective chart review. Compr Psychiatry 36:267–270.
   PubMed Web of Science ®Google Scholar
• Glick I, Poyurovsky M, Ivanova O, Koran L. 2008. Aripiprazole in schizophrenic patients with co-morbid obsessive–compulsive symptoms: an open label study of 15 patients. J Clin Psychiatry 69(12):1856–1859.
   Google Scholar
• Goodman WK, Price LH , Rausmussen SA. 1989. The Yale-Brown obsessive–compulsive scale (Y-BOCS). Part 1: development, use and reliability. Arch Gen Psychiatry 46: 1006–1011.
   PubMed Web of Science ®Google Scholar
• Goodman WK, McDougle CJ, Price LG, Riddle MA, Pauls DL, Lechman JF. 1990. Beyond the serotonin hypothesis: A role for dopamine in some forms of obsessive–compulsive disorder? J Clin Psychiatry 51:S36–43.
   PubMedGoogle Scholar
• Gross-Isseroff R, Hermesh H, Zohar J, Weitzman A. 2003. Neuro imaging communality between schizophrenia and obsessive–compulsive disorder. A putative basis for schizo-obsessive disorder? World J Biol Psychiatry 4(3):129–134.
   Google Scholar
• Hermesh H, Weitzman A, Gur S, Zalsman G, Shiloh R, Zohar J, . 2003. Alternation learning in OCD schizophrenia patients. Eur Neuropsychopharmacol 13(2):87–91.
   Google Scholar
• Heston LL. 1966. Psychiatric disorders in foster home reared children of schizophrenic mothers. Br J Psychiatry 112(489): 819–825.
   Google Scholar
• Hosak L. 2007. Role of the COMT gene Val158Met polymorphism in mental disorders: A review. Eur Psychiatry 22(5):276–281.
   Google Scholar
• Iida J, Matumura K, Aoyama F. 1998. Cerebral Mri findings in childhood-onset schizophrenia, comparison of patients with prodromal obsessive–compulsive symptoms and those without symptoms. Rec ProgChild Adolesc Psychiatry 2:75–83.
   Google Scholar
• Kapur S, Remington G. 1996. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153(4): 466–476.
   Google Scholar
• Karno M, Golding JM, Sorensen SB, Burnam MA. 1988. The epidemiology of obsessive–compulsive disorder in five US communities. Arch Gen Psychiatry 45:1094–1099.
   PubMed Web of Science ®Google Scholar
• Kayahan B, Ozturk O, Veznedaroglu B, Eraslan D. 2005. Obsessive–compulsive symptoms in schizophrenia; Prevalence and clinical correlates. Psychiatry Clin Neurosci 59:291–295.
   PubMed Web of Science ®Google Scholar
• Kendler KS. 1983. Overview: a current perspective on twin studies of schizophrenia. Am J Psychiatry 140(11):1413–1425.
   Google Scholar
• Key S, Opler L, Fiszbein A. 1991. Positive and Negative Syndrome Scale (PANSS) rating manual. Toronto: Multi-Health Systems Inc.
   Google Scholar
• Kim SW, Shin IS, Kim JM, Yang SJ, Hwang MY, Yoon JS. 2008. Amisulpride improves obsessive–compulsive symptoms in schizophrenia patients taking atypical antipsychotics. J Clin Psychoparmacol 28:349–352.
   PubMedGoogle Scholar
• Kopala L, Honer WG. 1994. Risperidone, serotonergic mechanisms and obsessive–compulsive symptoms in schizophrenia. Am J Psychiatry 151:1714–1715.
   PubMed Web of Science ®Google Scholar
• Lavin MR, Halligan P. 1996. ECT for co-morbid obsessive– compulsive disorder and schizophrenia. Am J Psychiatry 153: 1652–1653.
   Web of Science ®Google Scholar
• Lee MJ, Shin YB, Sunwoo YK, Jung SH, Kim WH, Kang MH, . 2009. Comparative analysis of cognitive function in schizophrenia with and without obsessive–compulsive disorder. Psychiatry Invest 6(4):286–293.
   Google Scholar
• Levkovich Y, Kronnenberg Y, Gaoni B. 1995. Can clozapine trigger OCD. J Am Acad Child Adolesc Psychiatry 34:263.
   Google Scholar
• Levy E, Margolese HC, Sultan S. 2003. Obsessive–compulsive symptoms in schizophrenia induced by risperidone and responding to fluoxetine. Can J Psychiatry 48(10):709–710.
   Google Scholar
• Levy-Ruelf J, Jurgens A, Loo H, Olie JP, Amado I. 2008. Maintenance electroconvulsive therapy and treatment of refractory schizophrenia. Encephale 34(5):526–533.
   Google Scholar
• Lim M, Dong YP, Jun SK, Yeon HJ, Kyung SH. 2007. Prevalence and clinical characteristics of obsessive–compulsive symptoms associated with atypical antipsychotics. J Clin Psychopharmacology 27(6):712–713.
   Google Scholar
• Lindenmayer JP, Vakharia M, Kanofsky D. 1990. Fluoxetine in chronic schizophrenia (letter). J Clin Psychoparmacol 10:76.
   PubMed Web of Science ®Google Scholar
• Lowing PA, Mirsky AF, Pereira R. 1983. The inheritance of schizophrenia spectrum disorders: a reanalysis of the Danish adoptee study data. Am J Psychiatry 140(9):1167–1171.
   Google Scholar
• Lykouras L, Zervas IM, Gournellis R, Malliori M, Rabavilas A. 2000. Olanzapine and obsessive-compulsive symptoms. Eur Neuropsychopharmacol 10:385–387.
   PubMed Web of Science ®Google Scholar
• Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A. 2003. Obsessive–compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry 27(3):333–346.
   Google Scholar
• Lysaker PH, Bryson GJ, Marks KA, Greig TC, Bell MD. 2002. Association of obsessions and compulsions in schizophrenia with neurocognition and negative symptoms. J Neuropsychiatry Clin Neurosci 14:449–453.
   PubMed Web of Science ®Google Scholar
• Lysaker PH, Marks KA, Picone JB, Rollins AL, Fastenau PS, Bond GR. 2000. Obsessive and compulsive symptoms in schizophrenia. Clinical and neurocognitive correlates. J Nerv Ment Dis 188:78–83.
   PubMed Web of Science ®Google Scholar
• Mahendran R, Liew E, Subramaniam M. 2007. De novo emergence of obsessive–compulsive symptoms with atypical antipsychotics in Asian patients with schizophrenia of schizoaffective disorder. A retrospective cross sectional study. J Clin Psychiatry 68(4):542–545.
   Google Scholar
• Mahendran R. 1998. Obsessional symptoms associated with risperidone treatment. Aust NZ J Psychiatry 32:299–301.
   PubMed Web of Science ®Google Scholar
• Mahendran R. 1999. Obsessive–compulsive symptoms with risperidone. J Clin Psychiatry 60:261.
   PubMedGoogle Scholar
• Maier W, Lichtermann D, Franke P, Heuns R, Falkai P, Rietschel M. 2002. The dichotomy of schizophrenia and affective disorders in extended pedigrees. Schizophr Res 57(2–3):259–266.
   Google Scholar
• Marks I. 1987. Fears, phobias and rituals. New York: Oxford University Press.
   Google Scholar
• McCabe JH, Travis M. 2004. Clozapine–induced obsessive– compulsive symptoms. Prog Neuropsychopharmacol Biol Psychiatry 28(7):1209.
   Google Scholar
• Metin O, Yazici K, Tot S, Yazici AE. 2003. Amisulpride augmentation in treatment of resistant obsessive-compulsive disorder: An open trial. Hum Psychopharmacol 18(6):463–467.
   Google Scholar
• Modell SC, Mountz JM, Curtis GC, Greden JF. 1989. Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalmocortical circuits as a pathogenetic mechanism of obsessive–compulsive disorder. J Neuropsychiatry Clin Neurosci 1:27–36.
   PubMedGoogle Scholar
• Morrison D, Clark D, Goldfarb E, McCoy L. 1998. Worsening of obsessive–compulsive symptoms following treatment with olanzapine. Am J Psychiatry 155:155.
   Google Scholar
• Mottard JP, De La Sablonniere JF. 1999. Olanzapine-induced obsessive–compulsive disorder (letter). Am J Psychiatry 156:799–800.
   PubMedGoogle Scholar
• Mozes T, Toren T, Chemauzan N, Mester R, Yoran-Hegesh R, Blumensohn R. 1994. Clozapine treatment in very early onset schizophrenia. J Am Acad Child Adolesc Psychiatry 33:65–70.
   PubMed Web of Science ®Google Scholar
• Nechmad A, Ratzoni F, Poyurovsky M, Meged S, Avidan G, Fuchs C, . 2003. obsessive–compulsive disorder in adolescent schizophrenic patients. Am J Psychiatry 160:1002–1004.
   PubMed Web of Science ®Google Scholar
• Norton N, Owen MJ. 2005. HTR2A: Association and expression studies in neuropsychiatric genetics. Ann Med 37(2): 121–129.
   Google Scholar
• Ongur D, Goff DC. 2005. Obsessive–compulsive symptoms in schizophrenia: Associated clinical features, cognitive function and medication status. Schizophr Res 75:349–362.
   PubMed Web of Science ®Google Scholar
• Owashi T, Ota A, Otsubo T, Susa Y, Kamijima K. 2010. Obsessive–compulsive disorder and obsessive–compulsive symptoms in Japanese inpatients with chronic schizophrenia – A possible schizophrenia subtype. Psychiatry Res 179(3):241–246.
   Google Scholar
• Ozer S, Arsava M, Ertugrul A, Demir B. 2006. Obsessive–compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: a case report. Prog Neuropsychopharmacol Biol Psychiatry 30(4):724–727.
   Google Scholar
• Patel B, Tandon R. 1993. Development of obsessive–compulsive symptoms during clozapine treatment. Am J Psychiatry 150:836.
   Google Scholar
• Patil VJ. 1992. Development of transient obsessive–compulsive symptoms during treatment with clozapine. Am J Psychiatry 149:272.
   PubMed Web of Science ®Google Scholar
• Pittman RK, Green RC, Jenike MA, Mesulam MM. 1989. Clinical comparison of Tourette's disorder and obsessive–compulsive disorder. Am J Psychiatry 144:1166–1171.
   Google Scholar
• Poyurovsky M, Hermesh H, Weitzman A. 1996. Fluvoxamine treatment in clozapine-induced obsessive–compulsive symptoms in schizophrenia. Clin Neuropharmacol 19:305–313.
   PubMed Web of Science ®Google Scholar
• Poyurovsky M, Isaacov V, Hromnikov S, Modai I, Rauchberger B, Schneidman M, Weizman A. 1999. Fluvoxamine treatment of obsessive–compulsive symptoms in schizophrenic patients: an add-on open study. Int Clin Psychopharmacol 14:95–100.
   PubMed Web of Science ®Google Scholar
• Poyurovsky M, Hromnikov S, Isaakov V, Rauchberger B, Modai I, Schneidman M . 2001. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res 102:49–57.
   PubMed Web of Science ®Google Scholar
• Poyurovsky M, Glick I, Koran L 2010. Lamotrigine augmentation in schizophrenic and schizoaffective patients with obsessive-compulsive symptoms. J. Psychopharmacol. Jun 24 (6): 861–866.
   Google Scholar
• Rajkumar RP, Reddy YC, Kandavel T. 2008. Clinical profile of “schizo-obsessive disorder”: A comparative study. Compr Psychiatry 49:262–268.
   Google Scholar
• Ramasubbu R, Ravindran A, Lapierre Y. 2000. Serotonin and dopamine antagonism in obsessive–compulsive disorder: Effect of atypical antipsychotic drugs. Pharmacopsychiatry 33: 236–238.
   PubMed Web of Science ®Google Scholar
• Remington G, Adams M. 1994. Risperidone and obsessive-compulsive symptoms (letter). J Clin Psychopharmacol 14: 358–359.
   PubMed Web of Science ®Google Scholar
• Resnick I, Sirota P. 2000a. An open study of fluvoxamine augmentation of neuroleptics in schizophrenia with obsessive–compulsive symptoms. J Clin Neuroparmocol 23(3):157–160.
   Google Scholar
• Resnick I, Sirota P. 2000b. Obsessive and compulsive symptoms in schizophrenia: A randomized controlled trial with fluvoxamine and neuroleptics. J Clin Neuropharmacol 20(4):410–416.
   Google Scholar
• Rosen I. 1956. The clinical significance of obsessions in schizophrenia. J Ment Sci 103:773–785.
   Google Scholar
• Sa AR, Hounie AG, Sampaio AS, Arrais J, Miguel EC , Elkis H. 2009. Obsessive–compulsive symptoms and disorder in patients with schizophrenia treated with clozapine of haloperidol. Compr Psychiatry 50(5):437–442.
   Google Scholar
• Saddock BJ, Saddock VA. 2007. Kaplan and Saddock's Synopsis of Psychiatry. 10th. Lippincott, Williams & Wilkins, Philadelphia.
   Google Scholar
• Sewell DD, Lopez WM, Paulsen J, Gilbert P. 1994. Treatment of obsessive–compulsive symptoms in schizophrenia with a neuroleptic-SSRI combination: Two case reports. J Nerv Ment Dis 182:725–727.
   Google Scholar
• Shih RA, Belmonte PL, Zandi PP. 2004. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 16(4):260–283.
   PubMedGoogle Scholar
• Shroll MP, Kasper S, Danos P, Holflish G, Moller HJ. 1994. Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia. Nervenarzt 65:478–481.
   Google Scholar
• Shustin VA, Korzenev AV, Gorskii GD, Vovin RI. 1991. Stereotaxic cingulotomy in the complex treatment of a schizophrenic patient with obsessive–compulsive disorder, resistant to treatment. Zh Nevropathol Psychiatr 91:92–95.
   Google Scholar
• Sinha BNP, Duggal HS, Nizamie SH. 2000. Risperidone induced obsessive–compulsive: a reappraisal. Can J Psychiatry 45: 397–398.
   Google Scholar
• Stamouli S, Lykouras L. 2006. Quetiapine-induced obsessive-compulsive symptoms. Aseries of 5 cases. J Clin Psychopharmacol 26(4):396–400.
   Google Scholar
• Stein DJ. 2000. Neurobiology of the obsessive–compulsive spectrum disorders. Biol Psychiatry 47(4):296–304.
   Google Scholar
• Stengal EA. 1945. A study of some clinical aspects of the relationship between obsessional neurosis and psychotic reaction types. J Ment Sci 91:166–187.
   Google Scholar
• Tandon R, Keshavan MS, Nasrallah HA. 2008. Schizophrenia “just the facts”, what we know in 2008. 2: Epidemiology and etiology. Schizophr Res 102:1–18.
   PubMed Web of Science ®Google Scholar
• Tejera CA, Mayerhoff DJ, Zafferman AZ, Ramos-Lorenzi JR. 1994. Fluoxetine for obsessional symptoms in schizophrenia (letter). Am J Psychiatry 150:149–150.
   Google Scholar
• Thomsen PH, Jensen J. 1994. Obsessive-compulsive disorder: admission patterns and diagnostic stability. A case-register study. Acta Psychiatr Scand 90:19–24.
   Google Scholar
• Tibbo P, Warneke L. 1999. Obsessive-compulsive disorder in schizophrenia: Epidemiologic and biologic overlap. J Psychiatr Neurosci 24:15–24.
   PubMed Web of Science ®Google Scholar
• Tibbo P, Kroetsch M, Chue P, Warneke L. 2000. Obsessive–compulsive disorder in schizophrenia. J Psychiatr Res 34:139–146.
   PubMed Web of Science ®Google Scholar
• Toren P, Samuel E, Weizman R, Golomb A, Eldar S, Laor N. 1995. Emergence of transient compulsive symptoms during treatment with clothiapine. J Am Acad Child Adolesc Psychiatry 34:1469–1472.
   Google Scholar
• Torgersen S. 1983. Genetic factors in anxiety disorders. Arch Gen Psychiatry 40(10):1085–1089.
   Google Scholar
• Ucok A, Ceylan E, Tihan AK, Lapcin S, Tukel R. 2010. Obsessive–compulsive disorder and symptoms may have different effects on schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry Sept 2010: Epub ahead of print.
   Google Scholar
• Van Nimwegen L, De Haan L, Van Beveren N , Laan W, van Den Brink W, Linszen D. 2008. Obsessive–compulsive symptoms in a randomized, double-blind study with olanzapine or risperidone in young patients with early psychosis. J Clin Psycopharmacol 28(2):214–218.
   Google Scholar
• Whitney KA, Fastenau PS, Evans JD, Lysaker PH. 2004. Comparative neuropsychological function in obsessive–compulsive disorder and schizophrenia with and without obsessive– compulsive symptoms. Schizophr Res 69:75–83.
   PubMed Web of Science ®Google Scholar
• Zink M, Knopf U, Kuwilsky A. 2007. Management of clozapine-induced obsessive–compulsive symptoms in a man with schizophrenia. Aust NZ J Psychiatry 41(3):293–294.
   Google Scholar
• Zinkstock J, Van Nimwegen L, Van Amelsvoort T, De Haan L, Abdulkadir M, Baas F, Linszen D. 2008. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: Preliminary results. Psychiatry Research 157: 1–8.
   Google Scholar
• Zohar J, Fostick L, Black D, Lopez-Ibor J. 2007. Special Populations. CNS Spectrums 12: 2 (Suppl. 3): 36–42.
   Google Scholar
• Zohar J, Kaplan Z, Benjamin J. 1993. Clomipramine treatment of obsessive-compulsive symptomatology in schizophrenic patients. J. Clin. Psychiatry; 54: 358–388.
   Google Scholar